Health Dictionary Find a Doctor

Atypical teratoid rhabdoid tumor pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Overview

Atypical teratoid rhabdoid tumor is comprised of rhabdoid tumor cells and varying amounts of small undifferentiated primitive neuroectodermal tumor (PNET)-like mesenchymal, and/or epithelial differentiated tumor cells. Gene involved in the pathogenesis of atypical teratoid rhabdoid tumor include SMARCB1 (hSNF5/INI-1), a tumor suppressor gene. Atypical teratoid rhabdoid tumor may be associated with rhabdoid predisposition syndrome. On gross pathology, atypical teratoid rhabdoid tumor is characterized by an encapsulated, grayish, friable mass which is moderately vascular. On microscopic histopathological analysis, atypical teratoid rhabdoid tumor is characterized by round blue tumor cells of high cellularity composed of atypical cells with eccentric nuclei, small nucleoli, and abundant amounts of eosinophilic cytoplasm with frequent mitotic figures. Atypical teratoid rhabdoid tumor is demonstrated by positivity to tumor markers such as epithelial membrane antigen, vimentin, and smooth muscle actin.

Pathophysiology

Pathophysiology

Pathogenesis

Genetics

Genetics

Associated Conditions

Associated Conditions

  • Atypical teratoid rhabdoid tumor may be associated with rhabdoid predisposition syndrome.[1]
Gross Pathology

Gross Pathology

  • On gross pathology, atypical teratoid rhabdoid tumor is characterized by an encapsulated, grayish, friable mass which is moderately vascular.[3]
  • Common intracranial sites associated with atypical teratoid rhabdoid tumor include:[4]
Infratentorial Supratentorial
Microscopic Pathology

Microscopic Pathology

Immunohistochemistry

Immunohistochemistry

  • Atypical teratoid rhabdoid tumor is demonstrated by positivity to tumor markers, such as:[5][6]
References

References

  1. 1.0 1.1 1.2 Slavc, Irene; Chocholous, Monika; Leiss, Ulrike; Haberler, Christine; Peyrl, Andreas; Azizi, Amedeo A.; Dieckmann, Karin; Woehrer, Adelheid; Peters, Christina; Widhalm, Georg; Dorfer, Christian; Czech, Thomas (2014). “Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992-2012”. Cancer Medicine. 3 (1): 91–100. doi:10.1002/cam4.161. ISSN 2045-7634.
  2. Ginn, Kevin F.; Gajjar, Amar (2012). “Atypical Teratoid Rhabdoid Tumor: Current Therapy and Future Directions”. Frontiers in Oncology. 2. doi:10.3389/fonc.2012.00114. ISSN 2234-943X.
  3. Chan KH, Mohammed Haspani MS, Tan YC, Kassim F (2011). “A case report of atypical teratoid/rhabdoid tumour in a 9-year-old girl”. Malays J Med Sci. 18 (3): 82–6. PMC 3216225. PMID 22135607.
  4. Location of Atypical teratoid/rhabdoid tumour. Dr Bruno Di Muzio and A.Prof Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/atypical-teratoidrhabdoid-tumour. Accessed on December 14, 2015
  5. Markers of Atypical teratoid/rhabdoid tumour. Dr Bruno Di Muzio and A.Prof Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/atypical-teratoidrhabdoid-tumour. Accessed on December 14, 2015
  6. Meyers SP, Khademian ZP, Biegel JA, Chuang SH, Korones DN, Zimmerman RA (2006). “Primary intracranial atypical teratoid/rhabdoid tumors of infancy and childhood: MRI features and patient outcomes”. AJNR Am J Neuroradiol. 27 (5): 962–71. PMID 16687525.

Template:WH Template:WS

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH